These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 22905234)
1. Amyloid-β acts as a regulator of neurotransmitter release disrupting the interaction between synaptophysin and VAMP2. Russell CL; Semerdjieva S; Empson RM; Austen BM; Beesley PW; Alifragis P PLoS One; 2012; 7(8):e43201. PubMed ID: 22905234 [TBL] [Abstract][Full Text] [Related]
2. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease. Koppensteiner P; Trinchese F; Fà M; Puzzo D; Gulisano W; Yan S; Poussin A; Liu S; Orozco I; Dale E; Teich AF; Palmeri A; Ninan I; Boehm S; Arancio O Sci Rep; 2016 Sep; 6():32553. PubMed ID: 27581852 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure. Yin Y; Zhao Y; Han S; Zhang N; Chen H; Wang X J Alzheimers Dis; 2017; 59(3):851-869. PubMed ID: 28697568 [TBL] [Abstract][Full Text] [Related]
4. Taipoxin induces synaptic vesicle exocytosis and disrupts the interaction of synaptophysin I with VAMP2. Bonanomi D; Pennuto M; Rigoni M; Rossetto O; Montecucco C; Valtorta F Mol Pharmacol; 2005 Jun; 67(6):1901-8. PubMed ID: 15695624 [TBL] [Abstract][Full Text] [Related]
5. Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid. Marsh J; Bagol SH; Williams RSB; Dickson G; Alifragis P Neurobiol Dis; 2017 Oct; 106():63-75. PubMed ID: 28647556 [TBL] [Abstract][Full Text] [Related]
6. Fluorescence resonance energy transfer detection of synaptophysin I and vesicle-associated membrane protein 2 interactions during exocytosis from single live synapses. Pennuto M; Dunlap D; Contestabile A; Benfenati F; Valtorta F Mol Biol Cell; 2002 Aug; 13(8):2706-17. PubMed ID: 12181340 [TBL] [Abstract][Full Text] [Related]
7. Amyloid-β Peptides Disrupt Interactions Between VAMP-2 and SNAP-25 in Neuronal Cells as Determined by FRET/FLIM. Sharda N; Pengo T; Wang Z; Kandimalla KK J Alzheimers Dis; 2020; 77(1):423-435. PubMed ID: 32675412 [TBL] [Abstract][Full Text] [Related]
8. Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory. Gulisano W; Melone M; Ripoli C; Tropea MR; Li Puma DD; Giunta S; Cocco S; Marcotulli D; Origlia N; Palmeri A; Arancio O; Conti F; Grassi C; Puzzo D J Neurosci; 2019 Jul; 39(30):5986-6000. PubMed ID: 31127002 [TBL] [Abstract][Full Text] [Related]
9. Aβ42-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways. Farizatto KLG; Ikonne US; Almeida MF; Ferrari MFR; Bahr BA PLoS One; 2017; 12(8):e0182895. PubMed ID: 28797057 [TBL] [Abstract][Full Text] [Related]
10. Sept8 controls the binding of vesicle-associated membrane protein 2 to synaptophysin. Ito H; Atsuzawa K; Morishita R; Usuda N; Sudo K; Iwamoto I; Mizutani K; Katoh-Semba R; Nozawa Y; Asano T; Nagata K J Neurochem; 2009 Feb; 108(4):867-80. PubMed ID: 19196426 [TBL] [Abstract][Full Text] [Related]
11. Chronic blockade of glutamate receptors enhances presynaptic release and downregulates the interaction between synaptophysin-synaptobrevin-vesicle-associated membrane protein 2. Bacci A; Coco S; Pravettoni E; Schenk U; Armano S; Frassoni C; Verderio C; De Camilli P; Matteoli M J Neurosci; 2001 Sep; 21(17):6588-96. PubMed ID: 11517248 [TBL] [Abstract][Full Text] [Related]
12. The ryanodine receptor-calstabin interaction stabilizer S107 protects hippocampal neurons from GABAergic synaptic alterations induced by Abeta42 oligomers. Hidisoglu E; Chiantia G; Franchino C; Tomagra G; Giustetto M; Carbone E; Carabelli V; Marcantoni A J Physiol; 2022 Dec; 600(24):5295-5309. PubMed ID: 36284365 [TBL] [Abstract][Full Text] [Related]
13. Synaptophysin I selectively specifies the exocytic pathway of synaptobrevin 2/VAMP2. Bonanomi D; Rusconi L; Colombo CA; Benfenati F; Valtorta F Biochem J; 2007 Jun; 404(3):525-34. PubMed ID: 17331077 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model. Kim DH; Lim H; Lee D; Choi SJ; Oh W; Yang YS; Oh JS; Hwang HH; Jeon HB Sci Rep; 2018 Jan; 8(1):354. PubMed ID: 29321508 [TBL] [Abstract][Full Text] [Related]
17. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin. Domínguez-Prieto M; Velasco A; Vega L; Tabernero A; Medina JM J Alzheimers Dis; 2017; 55(1):171-182. PubMed ID: 27662292 [TBL] [Abstract][Full Text] [Related]
18. Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions. Chiang HC; Iijima K; Hakker I; Zhong Y FASEB J; 2009 Jun; 23(6):1969-77. PubMed ID: 19255256 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells. Williams RSB; Bate C Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378 [TBL] [Abstract][Full Text] [Related]
20. Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease. Wuwongse S; Cheng SS; Wong GT; Hung CH; Zhang NQ; Ho YS; Law AC; Chang RC Biochim Biophys Acta; 2013 Dec; 1832(12):2245-56. PubMed ID: 23928361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]